Ken Griffin Reviva Pharmaceuticals Holdings, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 106,100 shares of RVPH stock, worth $100,795. This represents 0.0% of its overall portfolio holdings.
Number of Shares
106,100
Previous 121,800
12.89%
Holding current value
$100,795
Previous $460,000
70.65%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RVPH
# of Institutions
39Shares Held
6.77MCall Options Held
256KPut Options Held
77.1K-
Woodline Partners LP San Francisco, CA1.59MShares$1.51 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.24MShares$1.18 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$973,9860.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.01MShares$963,1010.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT505KShares$479,3700.1% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $19.4M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...